Literature DB >> 21173748

Free leptin index as a marker for leptin action in diabetes and obesity: leptin and soluble leptin receptors relationship with HbA1c.

Maciej Owecki1, Elżbieta Nikisch, Anna Miczke, Danuta Pupek-Musialik, Jerzy Sowiński.   

Abstract

OBJECTIVES: Glycosylated haemoglobin (HbA1c), leptin, leptin soluble receptors (sOB-R) and free leptin index (FLI) may all be influenced by diabetes, but their associations remain unclear. Therefore, we put forward a hypothesis that serum leptin, sOBR and FLI might be parallel to Hb1c, as they all reflect the metabolic status. DESIGN AND
SETTING: We measured leptin and sOB-R concentrations in 97 obese non-diabetic (47 women and 50 men), and 65 obese diabetic (32 women and 33 men) humans, and examined whether they were related to HbA1c. Under the condition, the presence of diabetes was the only differentiating factor between two groups of frankly obese humans.
RESULTS: Non-diabetic vs. diabetic, median and interquartile range, respectively: Leptin (ng/ml), 30.83, 37.27 vs. 28.24, 23.34; p>0.05; sOB-R (ng/ml), 17.62, 17.05 vs. 21.81, 16.61, p<0.05; FLI, 231.23, 310.00 vs. 131.76, 157.68, p<0.05. To investigate the influence of HbA1c on leptin and sOB-R, both groups were divided into tertiles based on HbA1c. In diabetics, leptin did not differ between the high, intermediate, and low HbA1c levels subgroups, p>0.05, and leptin was not influenced by HbA1c levels: r=0.086; p>0.05. For sOB-R, respectively: p>0.05; r=0.080; p>0.05. In non-diabetics, respectively: p<0.05; r=0.2923; p<0.05 for leptin; and p<0.0001, r=0.5103; p<0.0001, for s-OB-R.
CONCLUSIONS: Not leptin alone but serum sOB-R and FLI are the markers of leptin action impairment in type 2 diabetes. Further, HbA1c is not associated with metabolic status of leptin in obese diabetic patients, whereas this association is found in obese non-diabetic humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21173748

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  6 in total

1.  A Network Analysis of Biomarkers for Type 2 Diabetes.

Authors:  Tianyi Huang; Kimberly Glass; Oana A Zeleznik; Jae H Kang; Kerry L Ivey; Abhijeet R Sonawane; Brenda M Birmann; Craig P Hersh; Frank B Hu; Shelley S Tworoger
Journal:  Diabetes       Date:  2018-11-08       Impact factor: 9.461

2.  Leptin, Leptin Soluble Receptor, and the Free Leptin Index following a Diet and Physical Activity Lifestyle Intervention in Obese Males and Females.

Authors:  Jeffrey E Herrick; Gino S Panza; Jared M Gollie
Journal:  J Obes       Date:  2016-12-06

3.  Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir.

Authors:  Paweł Olczyk; Robert Koprowski; Katarzyna Komosinska-Vassev; Agnieszka Jura-Półtorak; Katarzyna Winsz-Szczotka; Kornelia Kuźnik-Trocha; Łukasz Mencner; Alicja Telega; Diana Ivanova; Krystyna Olczyk
Journal:  Molecules       Date:  2017-07-30       Impact factor: 4.411

4.  Platelet Serotonin Levels Are Associated with Plasma Soluble Leptin Receptor Concentrations in Normoglycemic Women.

Authors:  Luis Rodrigo Cataldo; José Suazo; Pablo Olmos; Carolina Bravo; José E Galgani; Malin Fex; J Alfredo Martínez; José L Santos
Journal:  J Diabetes Res       Date:  2019-05-02       Impact factor: 4.011

5.  Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes.

Authors:  Andreia Gameiro; Catarina Nascimento; Ana Catarina Urbano; Jorge Correia; Fernando Ferreira
Journal:  Front Vet Sci       Date:  2021-02-10

6.  Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss.

Authors:  E W Iepsen; J Lundgren; C Dirksen; J-Eb Jensen; O Pedersen; T Hansen; S Madsbad; J J Holst; S S Torekov
Journal:  Int J Obes (Lond)       Date:  2014-10-07       Impact factor: 5.095

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.